NEW YORK (GenomeWeb) – Bruker reported after the close of the market Wednesday that its first quarter revenues fell around 17 percent, largely due to divestitures, the negative effect of currency translation, and weak sales for its nuclear magnetic resonance business.

Bruker reported total revenues of $353.5 million for the three months ended March 31, down from $423.7 million for the first quarter of 2014 and below analysts' consensus estimate of $369.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.